momelotinib

English

Noun

momelotinib (uncountable)

1. (pharmacology) A medication belonging to the class of Janus kinase inhibitors, being developed as a drug to treat myelofibrosis.
   • 2021 December, Christine Liu, Jacqueline Kieltyka, Roy Fleischmann, Massimo Gadina, John J. O’Shea, “A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future?”, in Arthritis & Rheumatology, volume 73, number 12, →DOI, page 2173:

     Momelotinib is a JAK1/JAK2 inhibitor as well as an activin receptor–like kinase (ALK1) inhibitor. Because ALK1 is a receptor for bone morphogenic proteins, momelotinib is undergoing testing for the treatment of myelofibrosis (78).